Communication
RSC Advances
calcd for C23H25ClO4: 400.0000, found 401.1529 (M + H), 39.77, 39.50, 39.2, 38.94, 38.76, 31.45, 31.3, 28.97, 27.56, 26.69,
423.1328 (M + Na).
26.20, 25.75, 29; IR (cmꢁ1): 49, 2887, 2526, 1651, 1560, 1452,
5-Bromo-7-chloro-9-(2-hydroxy-4,4-dimethyl-6-oxo-cyclohex-1- 1363, 1279, 1245, 1185, 1133, 1063, 1007, 857, 765, 707, 538,
enyl)-3,3-dimethyl-2,3,4,9-tetrahydro-xanthen-1-one (Table 3, 500, 438; MS: 423 (M+), 425 (M+2) anal. calcd for C19H16BrClO4:
entry 6). Yield: 90%; mp 241–243 ꢀC; 1H NMR (300 MHz, CDCl3): C, 53.86; H, 3.81; Br, 18.86; Cl, 8.37; O, 15.11, found: C, 53.85;
d 10.34 (s, 1H, –OH), 7.36 (d, J ¼ 2.2 Hz, 1H, Ar–H), 6.90 (d, J ¼ H, 3.81.
2.0 Hz, 1H, Ar–H), 4.60 (s, 1H, –CH), 2.62 (q, J ¼ 17.7, 18.5 Hz,
5-Methoxy-2,3-dihydro-9-(2-hydroxy-5-oxocyclopent-1-enyl)-
2H, –CH2), 2.38 (d, J ¼ 4.5 Hz, 2H, –CH2), 2.31 (s, 2H, –CH2), 1.97 cyclopenta[b]chromen-1(9H)-one (Table 3, entry 14). Yield:
(s, 2H, –CH2), 1.16 (s, 3H, –CH3), 1.00–1.05 (m, 9H, 3-CH3); 13 84%; mp 257–260 ꢀC; 1H NMR (300 MHz DMSO): 2.29–2.36 (m,
C
NMR (300 MHz, CDCl3): d 196.47, 195.10, 163.43, 144.77, 6H, 3CH2), 2.72–2.74 (m, 2H, CH2), 3.82 (s, 3H, CH3O), 4.58 (s,
128.68, 127.79, 127.41, 126.35, 112.78, 109.93, 108.78, 94.79, 1H, CH), 6.58–6.60 (m, 1H, ArH), 6.92 (dd, J ¼ 8.0 Hz, J ¼ 1.2 Hz,
49.58, 49.03, 39.81, 30.77, 28.24, 26.92, 26.03, 25.64, 25.17; IR 1H, ArH), 6.99–7.03 (m, 1H, ArH), 11.80 (b, 1H, OH); IR (cmꢁ1):
(cmꢁ1): 3184, 2940, 1647, 1599, 1452, 1375, 1313, 1257, 1207, 3438, 3024, 2971, 2939, 1682, 1637, 1579, 1480, 1445, 1380,
1183, 1150, 1017, 887, 855, 803, 722, 662, 587, 475; MS: 479 (M+), 1322, 1273, 1255, 1237, 1170, 1125, 1076, 825, 788, 739, 716.
481 (M + 2). Anal. calcd for C23H24BrClO4: C, 57.58; H, 5.04; Br,
7-Bromo-2,3-dihydro-9-(2-hydroxy-5-oxocyclopent-1-enyl)-
16.65; Cl, 7.39; O, 13.34. Found: C, 57.57; H, 5.04; HRMS m/z cyclopenta[b]chromen-1(9H)-one (Table 3, entry 15). Yield:
calcd for C23H23ClBrO4: 478.0000, found 479.0618 (M + H), 86%; mp 280–282 ꢀC; 1H NMR (300 MHz DMSO): 2.26–2.43 (m,
481.0602 (M + 2) 501.0421 (M + Na), 503.0415 (M + Na + 2).
6H, 3CH2), 2.56–3.34 (m, 2H, CH2), 5.01 (s, 1H, CH), 7.01–7.24
9-(2-Hydroxy-6-oxo-cyclohex-1-enyl)-2,3,4,9-tetrahydro-xanthen- (m, 2H, ArH), 7.27 (d, J ¼ 8.4 Hz, 1H, ArH), 10.60 (b, 1H, OH); IR
1-one (Table 3, entry 7). Yield: 87%; mp 240–243 ꢀC; 1H NMR (300 (cmꢁ1): 3505, 2932, 2910, 1699, 1653, 1585, 1474, 1383, 1276,
MHz, CDCl3): d 10.00 (s, 1H, –OH), 6.80–7.14 (m, 4H, Ar–H), 4.84 1259, 1240, 1198, 1160, 1126, 1071, 1018, 818, 707, 659.
(s, 1H, –CH), 1.60–2.40 (m, 12H, 6-CH2); IR (cmꢁ1): 2951, 2538,
7-Nitro-2,3-dihydro-9-(2-hydroxy-5-oxocyclopent-1-enyl)cyclo-
1830, 1641, 1553, 1485, 1421, 1372, 1294, 1235, 1192, 1142, 1071, penta[b]chromen-1(9H)-one (Table 3, entry 16). Yield: 89%; mp
993, 924, 850, 773, 564, 493 MS: 311 (M + 1). Anal. calcd for 265–268C ꢀC; 1H NMR (300 MHz DMSO): 2.34–2.41 (m, 6H,
C19H18O4: C, 73.53; H, 5.85; O, 20.62. Found: C, 73.52; H, 5.84; 3CH2), 2.74–2.76 (m, 2H, CH2), 4.72 (s, 1H, CH), 7.41 (d, J ¼ 8.8
HRMS m/z calcd for C19H18O4: 310.0000, found 311.1295 (M + H), Hz, 1H, ArH), 7.87 (d, J ¼ 2.4 Hz, 1H, ArH), 8.11 (dd, J ¼ 8.8 Hz, J
333.1081 (M + Na).
¼ 2.4 Hz, 1H, ArH), 12.06 (b, 1H, OH). IR (cmꢁ1): 3512, 2943,
7-Bromo-9-(2-hydroxy-6-oxo-cyclohex-1-enyl)-2,3,4,9-tetrahydro- 2926, 1698, 1656, 1581, 1528, 1481, 1458, 1379, 1277, 1253, 1168,
xanthen-1-one (Table 3, entry 9). Yield: 88%; mp 238–240 C; H 1134, 1020, 929, 912, 840, 805, 748, 666.
1
ꢀ
NMR (300 MHz): d 10.75 (s, 1H, –OH), 7.25 (d, J ¼ 3.0 Hz, 1H, Ar–
7-Chloro-2,3-dihydro-9-(2-hydroxy-5-oxocyclopent-1-enyl)cyclo-
H), 7.09 (d, J ¼ 2.2 Hz, 1H, Ar–H), 6.89 (dd, J ¼ 5.2, 6.0 Hz, 1H, Ar– penta[b]chromen-1(9H)-one (Table 3, entry 17). Yield: 90%; mp
H), 4.57 (s, 1H, –CH), 1.76–2.85 (m, 12H, 6-CH2); 13C NMR (300 271–273 ꢀC; 1H NMR (300 MHz DMSO): 2.33–2.38 (m, 6H, 3CH2),
MHz, CDCl3): 202.18, 193.99, 167.43, 166.15, 148.45, 129.74, 2.71–2.73 (m, 2H, CH2), 4.60 (s, 1H, CH), 7.01 (dd, J ¼ 2.4 Hz, J ¼
129.28, 128.61, 126.86, 116.51, 116.10, 115.09, 47.57, 35.57, 35.02, 1.2 Hz, 1H, ArH), 7.18 (d, J ¼ 8.8 Hz, 1H, ArH), 7.27–7.30 (m, 1H,
33.26, 26.02, 22.80, 18.95; IR (cmꢁ1): 3105, 2955, 1640, 1596, 1477, ArH), 12.00 (b, 1H, OH); IR (cmꢁ1): 3508, 2935, 2914, 1699, 1654,
1374, 1279, 1233, 1186, 1144, 1070, 981, 819, 763, 620, 530, 470; 1583, 1477, 1409, 1384, 1277, 1259, 1240, 1162, 1126, 1018, 819,
MS: 389 (M + 1) 391 (M + 2); anal. calcd. For C19H17BrO4: C, 58.63; 677.
H, 4.40; Br, 20.53; O, 16.44, found: C, 58.63; H, 4.39; HRMS m/z
7,8-h-ph-9-(2-Hydroxy-4,4-dimethyl-6-oxocyclohex-1-enyl)-
calcd for C19H17BrO4: 389.0000, found 391.0551 (M + 2).
3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one (3h) (Table 4,
7-Chloro-9-(2-hydroxy-6-oxo-cyclohex-1-enyl)-2,3,4,9-tetrahydro- entry 1). Yield: 95% mp 235–237 ꢀC. 1H NMR (300 MHz, CDCl3)
xanthen-1-one (Table 3, entry 11). Yield: 94%; mp 242–244 ꢀC; 1H d ¼ 10.70 (s, 1H, OH), 7.78 (d, 1H, ArH), 7.73 (d, 2H, ArH), 7.48
NMR (500 MHz, CDCl3): d 10.76 (s, 1H, –OH), 7.09 (d, J ¼ 6.3 Hz, (t, 1H, ArH), 7.39 (t, 1H, ArH), 7.27 (d, 1H, ArH), 5.27 (s, 1H,
1H, Ar–H), 6.91–6.96 (m, 2H, Ar–H), 4.57 (s, 1H, –CH), 1.77–2.81 CH), 2.68 (ABq, J ¼ 17.6 Hz, 1H, CH2), 2.57 (ABq, J ¼ 17.6 Hz,
(m, 12H, 6-CH2); 13C NMR (300 MHz, CDCl3 + DMSO-d6): 201.86, 1H, CH2), 1.96 (ABq, J ¼ 16.4 Hz, 1H, CH2), 1.83 (ABq, J ¼ 16.4
193.94, 167.23, 165.96, 147.56, 127.13, 126.76, 125.61, 124.53, Hz, 1H, CH2), 2.36–2.41 (m, 4H, 4CH2), 1.17 (s, 3H, CH3), 1.08
115.52, 110.65, 99.74, 47.08, 35.47, 34.82, 33.05, 26.35, 22.69, (s, 3H, CH3), 0.95 (s, 3H, CH3), 0.72 (s, 3H, CH3) ppm; 13C NMR
19.03; IR (cmꢁ1): 3110, 2954, 1645, 1596, 1477, 1416, 1375, 1280, (300 MHz, CDCl3) d ¼ 201.11, 196.85, 170.22, 169.09, 148.89,
1239, 1188, 1141, 1068, 984, 917, 824, 576, 460; MS: 345 (M+), 347 131.26, 130.96, 158.54, 128.50, 126.71, 124.64, 122.87, 117.68,
(M + 2). Anal. calcd for C19H17ClO4: C, 66.19; H, 4.97; Cl, 10.28; O, 116.59, 116.14, 111.08, 50.71, 49.98, 43.18, 41.37, 32.42, 30.62,
18.56, found: C, 66.18; H, 4.97.
29.92, 29.33, 27.10, 26.37, 25.38 ppm; IR (KBr): 3182, 2941,
5-Bromo-7-chloro-9-(2-hydroxy-6-oxo-cyclohex-1-enyl)-2,3,4,9- 2862, 1643, 1593, 1464, 1373, 1315, 1261, 1235, 1061, 1026,
tetrahydro-xanthen-1-one (Table 3, entry 12). Yield: 91%; mp 888, 813 cmꢁ1
.
1
ꢀ
238–240 C; H NMR (300 MHz, CDCl3): d 10.44 (s, 1H, –OH),
7.30 (d, J ¼ 2.6 Hz, 1H, Ar–H), 6.95 (d, J ¼ 1.7 Hz, 1H, Ar–H),
Conclusions
5.04 (s, 1H, –CH), 1.93–2.12 (m, 4H, 2-CH2), 2.25–2.51 (m, 8H,
4-CH2); 13C NMR (300 MHz, CDCl3): 195.44, 163.90, 145.45, In conclusion, we developed a simpler, more convenient, and
129.31, 128.72, 127.93, 110.62, 109.50, 50.29, 40.33, 40.05, more efficient procedure for synthesis of benzopyran from the
This journal is © The Royal Society of Chemistry 2015
RSC Adv., 2015, 5, 84610–84620 | 84619